Trials / Completed
CompletedNCT03880266
A Study of Glycopyrronium Cloth, 2.4% in Patients With Palmar Hyperhidrosis
A Phase 2, Randomized, Double-blind, Vehicle-controlled Efficacy and Safety Study of Glycopyrronium Cloth, 2.4% in Patients With Palmar Hyperhidrosis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 72 (actual)
- Sponsor
- Journey Medical Corporation · Industry
- Sex
- All
- Age
- 9 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to assess the efficacy and safety of glycopyrronium cloth, 2.4% when used to treat palmar hyperhidrosis.
Detailed description
This is a pilot study assessing the safety and efficacy of glycopyrronium cloth in patients with palmar hyperhidrosis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Glycopyrronium cloth, 2.4% | Pre-saturated 100% polypropylene, nonwoven, fabric cloth with glycopyrronium |
| DRUG | Vehicle | Pre-saturated 100% polypropylene, nonwoven, fabric cloth |
Timeline
- Start date
- 2019-02-22
- Primary completion
- 2019-05-24
- Completion
- 2019-05-24
- First posted
- 2019-03-19
- Last updated
- 2021-08-25
- Results posted
- 2021-03-15
Locations
7 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03880266. Inclusion in this directory is not an endorsement.